Falling prices might lead 33% of U.S. adults to try GLP-1 weight-loss drugs

By Allison Bell

News December 04, 2025 at 12:51 PM

Share & Print

What You Need To Know

About 5.1% of U.S. adults told eHealth they are taking GLP-1 agonists today.
Another 33% want to try the drugs if and when the price comes down.
Half are willing to pay more than $200 per month for access.

More From HR Executive

NOT FOR REPRINT

© Arc, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.